3D-QSAR study of 20 (S)-camptothecin analogs.

Acta Pharmacol Sin

Jiangsu Simcere Pharmaceutical Research Company Ltd, Nanjing 210042, China.

Published: February 2007

Aim: To build up a quantitative structure-activity relationship (QSAR) model of 20 (S)-camptothecin (CPT) analogs for the prediction of the activity of new CPT analogs for drug design.

Methods: A training set of 43 structurally diverse CPT analogs which were inhibitors of topoisomerase I were used to construct a quantitative structure-activity relationship model with a comparative molecular field analysis (CoMFA). The QSAR model was optimized using partial least squares (PLS) analysis. A test set of 10 compounds was evaluated using the model.

Results: The CoMFA model was constructed successfully, and a good cross-validated correlation was obtained in which q(2) was 0.495. Then, the analysis of the non-cross-validated PLS model in which r(2) was 0.935 was built and permitted demonstrations of high predictability for the activities of the 10 CPT analogs in the test set selected in random.

Conclusion: The CoMFA model indicated that bulky negative-charged group at position 9, 10 and 11 of CPT would increase activity, but excessively increasing bulky group at position 10 is adverse to inhibitory activity; substituents that occupy position 7 with the bulky positive group will enhance the inhibitive activity. The model can be used to design new CPT analogs and understand the mechanism of action.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1745-7254.2007.00477.xDOI Listing

Publication Analysis

Top Keywords

cpt analogs
20
quantitative structure-activity
8
structure-activity relationship
8
qsar model
8
test set
8
comfa model
8
group position
8
model
7
analogs
6
cpt
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!